Topics
The Retina Pipeline
Individualized Structure-function Correlations in Intermediate AMD
Sponsored by NIDEK
View Insert
Retina Pipeline 2023: A View Into Ongoing Innovation
Editorially independent content supported by advertising from Genentech
View Interactive Supplement
One to Watch: Akshay Thomas, MD, MS
Sponsored by Allergan
Finding Another Solution: An Update on OTX-TKI
Supported by Ocular Therapeutix, Inc.
Inherited Retinal Diseases: Advances in Clinical Diagnosis, Genetic Testing, and Gene Therapies
This activity is provided by PRIME Education.
View Supplement
The Era of Anti-VEGF Biosimilars: Navigating the Treatment Paradigm for Retinal Vascular Diseases
This activity is supported by an unrestricted educational grant from Regeneron.
Following the Signs: Practical Pearls for Diagnosing and Managing Uveitis
This activity is supported by an unrestricted educational grant from EyePoint Pharmaceuticals.
Achieving New Heights of Durability in Retina: What’s in Store for Retina Treatments and the Patients Who Need Them
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Business Matters: Understanding and Preventing Physician Burnout
Editorially independent content supported with advertising by Iveric Bio
Targeting the Suprachoroidal Space: Current Evidence and Best Practices for the Treatment of Posterior Segment Eye Diseases
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Retina Surgical Rounds
One to Watch: Nimesh A. Patel, MD
Supported by Allergan
Diabetic Eye Disease
The Benefits of Smaller-Gauge, High-Speed, Dual-Blade Vitrectomy Cutters in Vitreous Opacity Surgery
Content Supported by Alcon Medical Affairs
One To Watch: Ferhina S. Ali, MD, MPH
The Clinical and Economic Argument for MicroPulse® Laser in a Retinal Practice
Sponsored by Iridex
Current Practice and Future Options for Nonproliferative Diabetic Retinopathy
Sponsored by OcuTerra Therapeutics
Business Matters: Keeping Your Data Secure
Editorially independent content supported with advertising by Regeneron and Iveric Bio
Rare and Inherited Retinal Diseases
Two Sisters, Two Systems, One View
Sponsored by Oculus Surgical
One to Watch: Jayanth Sridhar, MD
Supported by Allergan, an AbbVie company
Clinical Case Compendium
Editorially Independent Content, Supported With Advertising From Bausch + Lomb and Nidek
Advances in AMD Care
Shifting the Paradigm
Sponsored by OcuTerra
One to Watch: Avni P. Finn, MD, MBA
Anti-VEGF Crunch Syndrome in PDR
Sponsored by NIDEKMirante does not have US FDA clearance.
Best Practices on Referring Patients With Symptomatic Vitreous Opacities
Editorially Independent Content, Supported with Advertising from Alcon Surgical and LumiThera
Business Matters: Tips for a Savvy Money Manager
Exploring a New Era in Retinal Disease Treatments
Imaging and Visualization
One to Watch: Brian K. Do, MD
Diversity and Inclusion In Retina
Considerations on the Management of Macular Neovascularization in Patients with Geographic Atrophy Enrolled in Clinical Trials
Sponsored by Iveric Bio
Photodynamic Therapy: Evolving Treatment Strategies and Keys to Effective Delivery
The Why and How of Going Solo
Techniques and Technologies
One To Watch
Explore the Complement System
Treatment of Posterior Segment Disease: Exploring the Suprachoroidal Space
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
